查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942491

2026年全球乳癌筛检测试市场报告

Breast Cancer Screening Test Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

乳癌検诊市场规模は近年、着しい成长を遂げております。2025年の24亿9,000万米ドルから2026年には26亿9,000万米ドルへと、CAGR8.3％で拡大が见込まれております。过去数年间の成长は、乳癌発症率への认识の高まり、乳房X光摄影検诊プログラムの広范な导入、诊断検査インフラの拡充、标准化された検诊ガイドラインの整备、公众卫生検诊施策の拡大などが要因として挙げられます。

乳癌検诊検査市场规模は今后数年间で力强い成长が见込まれます。2030年には36亿8,000万米ドルに达し、CAGRは8.1％となる见込みです。予测期间における成长は、个别化がん検诊通讯协定の采用増加、AI搭载诊断ツールの利用拡大、遗伝子検査导入の拡大、早期がん検出への注目の高まり、予防肿疡学サービスへの投资増加に起因すると考えられます。予测期间の主な动向としては、高度な画像诊断ベースの筛检検査の采用増加、遗伝子・分子诊断の利用拡大、画像解釈におけるAI统合の进展、多模态筛检手法の拡大、早期・予防诊断への注目の强化が挙げられます。

The increasing incidence of 乳癌 is expected to drive the growth of the 乳癌 cancer screening market. 乳癌 involves the abnormal and uncontrolled growth of cells in breast tissue, which can develop inich canun​​yal thes in sun​​hed sek, s​​an can deconnect in s​​stal's in s​​stal the s​​stal the s​​d the sper​​als in the soc​​als in soc​​al's in s​​an can deals in乳癌。 cancer cases is due to the aging global population, which significantly increases the risk of developing the disease, and longer life expectancies put more individuals at risk. 乳癌 screening is , for tecning isting sat form​​ly 论文 5 月 is improve treatment outcomes and reduce mortality. For example, in March 2025, Breastcancer.org, a US-based non-profit organization, predicted that approximately 316,950 women will be diagnosed with invasive 乳癌 in 2025, and an additional 59,080 new cases of ductal 乳癌，其中5500人将死于乳腺癌。在此背景下，乳癌发生率的上升是乳癌筛检市场扩张的原因之一。

乳癌検诊テスト分野の主要企业は、アクセスの向上、早期発见の促进、医疗サービスが行き届いていない地域や远隔地へのサービス拡大を目的として、移动式検诊ユニットなどの先进的なソリューションの开発を优先しています。これらの移动式ユニットは、マンモグラフィーなどの画像诊断技术を备えた可携式施设であり、十分な医疗アクセスが得られない地域で现地での乳癌検诊を提供するために设计されています。例えば、2024年9月には、インドに本拠を置く製薬会社であるGranules India Ltd.が、恵まれないコミュニティにおける乳癌検诊を促进するため、「Breast Health Express」を导入しました。このユニットは、高度なマンモグラフィーおよび超音波システムを装备しており、移动しながら质の高い検诊を可能にします。この取り组みは、农村部や医疗サービスが行き届いていない地域に早期発见サービスをもたらし、これらの地域の女性たちが重要な医疗サービスを受けられるよう支援することを目的としています。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球乳癌筛检市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 扩大基于先进诊断影像技术的筛检检测方法的应用范围
    • 基因和分子诊断技术的广泛应用
    • 人工智慧在影像分析中的整合进展
    • 扩展多模态筛检方法
    • 人们越来越关注早期和预防性诊断

第五章 终端用户产业市场分析

  • 医院
  • 诊断中心
  • 癌症研究所
  • 研究所
  • 专科肿瘤诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球乳癌筛检测试市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球乳癌筛检市场规模、比较及成长率分析
  • 全球乳癌筛检测试市场表现：规模与成长，2020-2025年
  • 全球乳癌筛检市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 按诊断测试类型
  • 血液标记检测、影像检查、基因检测、免疫组织化学检测
  • 按风险等级
  • 高风险族群、中风险族群和平均风险族群
  • 最终用户
  • 医院、诊断中心、癌症研究所、研究实验室
  • 按类型细分：血液标记检测
  • 循环性肿瘤细胞（CTC）检测、基因表现检测、循环肿瘤DNA（ctDNA）检测、蛋白质体学生物标记检测
  • 按类型细分：影像检查
  • 乳房X光摄影、磁振造影筛检、分子乳房影像、正子断层扫描和超音波
  • 按类型细分：基因检测
  • 萤光原位杂合反应，HER基因检测
  • 按类型细分：免疫组织化学
  • 雌激素受体 (ER) 检测、Ki-67 增殖标记检测、黄体素受体 (PR) 检测、HER2 或 Neu 检测

第十章 区域与国家分析

  • 全球乳癌筛检市场：依地区划分，结果及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球乳癌筛检市场：依国家划分，结果及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章 イタリア市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 乳癌筛检测试市场：竞争格局与市场份额，2024 年
  • 乳癌筛检测试市场：公司估值矩阵
  • 乳癌筛检测试市场：公司概况
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Siemens Healthcare GmbH
    • Fujifilm Corporation

第37章：其他领先和创新企业

  • Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., BD（Becton, Dickinson and Company）, Agilent Technologies Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年乳癌筛检市场：提供新机会的国家
  • 2030年乳癌筛检市场：新兴细分市场机会
  • 2030年乳癌筛检市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MBCST01_G26Q1

A breast cancer screening test is a medical procedure or diagnostic method designed to detect breast cancer at an early stage, often before any symptoms develop. The main objective of screening is to discover cancer when it is most treatable, thereby potentially lowering mortality rates and enhancing patient outcomes. Early diagnosis through breast cancer screening enables timely treatment and leads to a more favorable prognosis.

The primary types of diagnostic tests used in breast cancer screening include blood marker tests, imaging tests, genetic tests, and immunohistochemistry tests. Blood marker tests identify and quantify specific substances in the blood to support disease detection, monitoring, or risk evaluation. Different levels of risk-high-risk, moderate-risk, and average-risk populations-are considered, and the tests are utilized by various end users, including hospitals, diagnostic centers, cancer institutes, and research laboratories.

Tariffs are influencing the breast cancer screening test market by increasing costs of imported imaging equipment, diagnostic reagents, genetic testing kits, and advanced laboratory instruments. Diagnostic centers and hospitals in North America and Europe are most affected due to dependence on imported imaging systems and consumables, while Asia-Pacific faces higher costs for test kit manufacturing and exports. These tariffs are increasing screening service costs and slowing equipment upgrades. However, they are also supporting local manufacturing of diagnostic kits, regional laboratory expansion, and domestic development of screening technologies.

The breast cancer screening test market research report is one of a series of new reports from The Business Research Company that provides breast cancer screening test market statistics, including breast cancer screening test industry global market size, regional shares, competitors with a breast cancer screening test market share, detailed breast cancer screening test market segments, market trends and opportunities, and any further data you may need to thrive in the breast cancer screening test industry. This breast cancer screening test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The breast cancer screening test market size has grown strongly in recent years. It will grow from $2.49 billion in 2025 to $2.69 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing breast cancer incidence awareness, widespread deployment of mammography screening programs, expansion of diagnostic laboratory infrastructure, availability of standardized screening guidelines, growing public health screening initiatives.

The breast cancer screening test market size is expected to see strong growth in the next few years. It will grow to $3.68 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rising adoption of personalized cancer screening protocols, increasing use of ai-powered diagnostic tools, expansion of genetic testing adoption, growing focus on early-stage cancer detection, increasing investments in preventive oncology services. Major trends in the forecast period include increasing adoption of advanced imaging-based screening tests, rising use of genetic and molecular diagnostics, growing integration of ai in image interpretation, expansion of multi-modal screening approaches, enhanced focus on early and preventive diagnostics.

The increasing incidence of breast cancer is anticipated to drive the growth of the breast cancer screening test market. Breast cancer involves the abnormal and uncontrolled growth of cells in breast tissue, which can develop into a tumor and potentially spread to other body parts. The rise in breast cancer cases is attributed to the aging global population, as older age significantly raises the risk of developing the disease, and longer life expectancies mean a greater number of individuals are at risk. Screening tests for breast cancer are essential for identifying the disease in its early stages, thereby improving treatment outcomes and lowering mortality rates. For example, in March 2025, Breastcancer.org, a nonprofit organization based in the US, projected that approximately 316,950 women would be diagnosed with invasive breast cancer in 2025, along with 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Additionally, in December 2024, the Public Health Agency of Canada reported that an estimated 28,600 women in Canada were expected to be diagnosed with breast cancer in 2022, with 5,500 fatalities anticipated. As a result, the rising prevalence of breast cancer is contributing to the expansion of the breast cancer screening test market.

Leading companies in the breast cancer screening test sector are prioritizing the development of cutting-edge solutions such as mobile screening units to improve accessibility, increase early detection, and extend services to underserved or remote regions. These mobile units are transportable facilities equipped with diagnostic imaging technologies like mammography, designed to deliver on-site breast cancer screening in areas lacking adequate healthcare access. For instance, in September 2024, Granules India Ltd., a pharmaceutical company based in India, introduced the Breast Health Express to promote breast cancer screening in disadvantaged communities. Outfitted with advanced mammography and ultrasound systems, the unit facilitates quality screenings while on the move. This initiative aims to bring early detection services to rural and underserved areas, helping to ensure access to critical healthcare for women in these regions.

In August 2024, Hitachi High-Tech Corporation, a Japan-based producer of electronic and electrical equipment, entered into a strategic alliance with Gencurix Inc. for an undisclosed amount. Through this collaboration, Hitachi seeks to utilize its knowledge in in vitro diagnostics and digital technologies to create accurate and efficient molecular diagnostics for cancer. Gencurix Inc., headquartered in South Korea, specializes in breast cancer testing solutions.

Major companies operating in the breast cancer screening test market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Fujifilm Corporation, Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., BD (Becton Dickinson and Company), Agilent Technologies Inc.

North America was the largest region in the breast cancer screening test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast cancer screening test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the breast cancer screening test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The breast cancer screening test market consists of revenues earned by entities by providing services such as early detection, risk assessment, and tumor detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast cancer screening test market also consists of sales of products including ultrasound equipment, screening software, and breast self-examination kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Breast Cancer Screening Test Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses breast cancer screening test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for breast cancer screening test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The breast cancer screening test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Diagnostic Test Type: Blood Marker Test; Imaging Test; Genetic Test; Immunohistochemistry Test
  • 2) By Risk Level: High-risk Population; Moderate-risk Population; Average-risk Population
  • 3) By End User: Hospitals; Diagnostic Centres; Cancer Institutes; Research Laboratories
  • Subsegments:
  • 1) By Blood Marker Test: Circulating Tumor Cells (Ctcs) Test; Gene Expression Profiling Test; Circulating Tumor Dna (Ctdna) Test; Proteomic Biomarker Test
  • 2) By Imaging Test: Mammography; Magnetic Resonance Imaging Screening Test; Molecular Breast Imaging Test; Positron Emission Mammography; Ultrasound
  • 3) By Genetic Test: Fluorescence In Situ Hybridization; Her Gene Test
  • 4) By Immunohistochemistry (Ihc) Test: Estrogen Receptor (Er) Test; Ki-67 Proliferation Marker Test; Progesterone Receptor (Pr) Test; Her2 Or Neu Test
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthcare GmbH; Fujifilm Corporation; Koninklijke Philips NV; GE HealthCare Technologies Inc.; Quest Diagnostics Incorporated; Hologic Inc.; Hitachi High-Tech Corporation; Exact Sciences Corporation; Natera Inc.; Myriad Genetics Inc.; Canon Medical Systems Corporation; Provista Diagnostics Inc.; Niramai Health Analytix Pvt. Ltd.; Kheiron Medical Technologies Limited; UE LifeSciences Inc.; BD (Becton Dickinson and Company); Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Breast Cancer Screening Test Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Breast Cancer Screening Test Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Breast Cancer Screening Test Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Breast Cancer Screening Test Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Advanced Imaging-Based Screening Tests
    • 4.2.2 Rising Use Of Genetic And Molecular Diagnostics
    • 4.2.3 Growing Integration Of Ai In Image Interpretation
    • 4.2.4 Expansion Of Multi-Modal Screening Approaches
    • 4.2.5 Enhanced Focus On Early And Preventive Diagnostics

5. Breast Cancer Screening Test Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Centres
  • 5.3 Cancer Institutes
  • 5.4 Research Laboratories
  • 5.5 Specialty Oncology Clinics

6. Breast Cancer Screening Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Breast Cancer Screening Test Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Breast Cancer Screening Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Breast Cancer Screening Test Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Breast Cancer Screening Test Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Breast Cancer Screening Test Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Breast Cancer Screening Test Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Breast Cancer Screening Test Market Segmentation

  • 9.1. Global Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Marker Test, Imaging Test, Genetic Test, Immunohistochemistry Test
  • 9.2. Global Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • High-risk Population, Moderate-risk Population, Average-risk Population
  • 9.3. Global Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Centres, Cancer Institutes, Research Laboratories
  • 9.4. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Blood Marker Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Circulating Tumor Cells (Ctcs) Test, Gene Expression Profiling Test, Circulating Tumor Dna (Ctdna) Test, Proteomic Biomarker Test
  • 9.5. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Mammography, Magnetic Resonance Imaging Screening Test, Molecular Breast Imaging Test, Positron Emission Mammography, Ultrasound
  • 9.6. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Genetic Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fluorescence In Situ Hybridization, Her Gene Test
  • 9.7. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Immunohistochemistry Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Estrogen Receptor (Er) Test, Ki-67 Proliferation Marker Test, Progesterone Receptor (Pr) Test, Her2 Or Neu Test

10. Breast Cancer Screening Test Market Regional And Country Analysis

  • 10.1. Global Breast Cancer Screening Test Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Breast Cancer Screening Test Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Breast Cancer Screening Test Market

  • 11.1. Asia-Pacific Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Breast Cancer Screening Test Market

  • 12.1. China Breast Cancer Screening Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Breast Cancer Screening Test Market

  • 13.1. India Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Breast Cancer Screening Test Market

  • 14.1. Japan Breast Cancer Screening Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Breast Cancer Screening Test Market

  • 15.1. Australia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Breast Cancer Screening Test Market

  • 16.1. Indonesia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Breast Cancer Screening Test Market

  • 17.1. South Korea Breast Cancer Screening Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Breast Cancer Screening Test Market

  • 18.1. Taiwan Breast Cancer Screening Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Breast Cancer Screening Test Market

  • 19.1. South East Asia Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Breast Cancer Screening Test Market

  • 20.1. Western Europe Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Breast Cancer Screening Test Market

  • 21.1. UK Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Breast Cancer Screening Test Market

  • 22.1. Germany Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Breast Cancer Screening Test Market

  • 23.1. France Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Breast Cancer Screening Test Market

  • 24.1. Italy Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Breast Cancer Screening Test Market

  • 25.1. Spain Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Breast Cancer Screening Test Market

  • 26.1. Eastern Europe Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Breast Cancer Screening Test Market

  • 27.1. Russia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Breast Cancer Screening Test Market

  • 28.1. North America Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Breast Cancer Screening Test Market

  • 29.1. USA Breast Cancer Screening Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Breast Cancer Screening Test Market

  • 30.1. Canada Breast Cancer Screening Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Breast Cancer Screening Test Market

  • 31.1. South America Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Breast Cancer Screening Test Market

  • 32.1. Brazil Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Breast Cancer Screening Test Market

  • 33.1. Middle East Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Breast Cancer Screening Test Market

  • 34.1. Africa Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Breast Cancer Screening Test Market Regulatory and Investment Landscape

36. Breast Cancer Screening Test Market Competitive Landscape And Company Profiles

  • 36.1. Breast Cancer Screening Test Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Breast Cancer Screening Test Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Breast Cancer Screening Test Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Fujifilm Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Breast Cancer Screening Test Market Other Major And Innovative Companies

  • Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., BD (Becton, Dickinson and Company), Agilent Technologies Inc.

38. Global Breast Cancer Screening Test Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Breast Cancer Screening Test Market

40. Breast Cancer Screening Test Market High Potential Countries, Segments and Strategies

  • 40.1 Breast Cancer Screening Test Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Breast Cancer Screening Test Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Breast Cancer Screening Test Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer